ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

IOM appoints 22 to National Cancer Policy Forum.

July 1, 2005

Regulatory Agencies: FDA To Increase Fees For Mammography Facility Inspections

January 30, 1998

NCI Reports On Efforts To Prevent Cancer In Native Americans

August 13, 1999

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977